Finanças

Notícias Discussões Sinais técnicos Previsão Sazonais

Total de custos operacionais de SICHUAN BIOKIN PHARMACEUTICAL CO LT.

Dados anuais

2020

2021

2022

2023

2024

TTM

‪‪−2,00 B‬‬

‪‪−1,50 B‬‬

‪‪−1,00 B‬‬

‪‪−500,00 M‬‬

‪0,00‬

Período

Valor

Variação

Variação %

TTM

‪‪−1,91 B‬‬

‪‪−78,53 M‬‬

‪−4,29‬%

2024

‪‪−1,83 B‬‬

‪‪−478,69 M‬‬

‪−35,46‬%

2023

‪‪−1,35 B‬‬

‪‪−326,53 M‬‬

‪−31,91‬%

2022

‪‪−1,02 B‬‬

‪‪−77,65 M‬‬

‪−8,21‬%

2021

‪‪−945,76 M‬‬

+‪‪85,70 M‬‬

+‪8,31‬%

2020

‪‪−1,03 B‬‬

+‪‪211,00 M‬‬

+‪16,98‬%

Dados trimestrais

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪‪−600,00 M‬‬

‪‪−450,00 M‬‬

‪‪−300,00 M‬‬

‪‪−150,00 M‬‬

‪0,00‬

Período

Valor

Variação

Variação %

Q4 '24

‪‪−515,86 M‬‬

+‪‪32,99 M‬‬

+‪6,01‬%

Q3 '24

‪‪−548,85 M‬‬

‪‪−105,42 M‬‬

‪−23,77‬%

Q2 '24

‪‪−443,43 M‬‬

‪‪−44,41 M‬‬

‪−11,13‬%

Q1 '24

‪‪−399,03 M‬‬

+‪‪24,39 M‬‬

+‪5,76‬%

Q4 '23

‪‪−423,41 M‬‬

‪‪−142,73 M‬‬

‪−50,85‬%

Q3 '23

‪‪−280,68 M‬‬

+‪‪71,76 M‬‬

+‪20,36‬%

Q2 '23

‪‪−352,44 M‬‬

‪‪−59,03 M‬‬

‪−20,12‬%

Q1 '23

‪‪−293,41 M‬‬

‪‪−120,54 M‬‬

‪−69,72‬%

Q4 '22